Levine Leichtman Capital Partners, a private equity firm based in Beverly Hills, partnered with management to purchase Capsa Healthcare, a global provider of mobile workstations, medication management tools and pharmacy automation systems, company officials announced Monday.
Levine Leichtman purchased the Portland-based healthcare company from Keystone Capital Inc. of Chicago. Terms and timing of the sale were not disclosed. Levine Leichtman officials said Capsa’s management team retained a minority ownership stake.
“We are excited to partner with Andrew Sherrill, CEO and the rest of the Capsa management team, who have successfully built a market leading company in an attractive segment of the health care industry,” Levine Leichtman partner Aaron Perlmutter said in a statement.
Kirkland & Ellis provided legal guidance to Leichtman. Midcap Financial of Los Angeles, NewStar Financial of Boston and Madison Capital of New York helped finance the deal. London investment bank Harris Williams & Co. advised Capsa on the sale.
Capsa has production facilities in Columbus, Ohio, and Agua Prieta Mexico, and serves more than 3,000 health care systems, senior care communities and major retail and institutional pharmacies.
This is the second health care-related acquisition Levine Leichtman made in the past two weeks. Earlier this month the private equity firm struck a deal with Therapeutic Research Center’s management to purchase the Stockton pharmacist education company for an undisclosed sum.
Health business reporter Dana Bartholomew can be reached at email@example.com. Follow him on Twitter @_DanaBart.
For reprint and licensing requests for this article, CLICK HERE.
Stories You May Also Be Interested In
- Clearlake’s Symplr Acquires API Healthcare
- ARTHUR LEVINE
- Marlin Equity Partners Picks Up Majority Piece of Talkwalker
- 36. Arthur Levine & Lauren Leichtman
- LAUREN LEICHTMAN
- PE Roundup: Private Equity Deals and Funds Announced May 16-20
- Levine Leichtman Capital Partners Sells Fastsigns
- Crescent Capital Group Finances Purchase of European Pharmacies